SynthesisFrontiers in oncology2022

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis.

Fang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.